Showing results (81-90 of 183) with videos related to

Sort By:
Pageof 19
Blood|October 1, 2005
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALLDavid T Teachey, Dana A Obzut, Jonathan Cooperman, et al.
Investigational New Drugs|February 28, 2013
Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndromeIvana Gojo, Alexander Perl, Selina Luger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2022
Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid LeukemiaNaval Daver, Alexander E Perl, Joseph Maly, et al.
Archives of Pathology & Laboratory Medicine|September 2, 2025
QuANTUM-First: Clinical Validation of the LeukoStrat Companion Diagnostic for the Selection of Patients With Acute Myeloid Leukemia Harboring FMS-Like Tyrosine Kinase 3-Internal Tandem Duplications for Treatment With QuizartinibJaime E Connolly Rohrbach, Ken C N Chang, Maha Karnoub, et al.
Blood Advances|April 25, 2020
A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemiaCatherine C Smith, Mark J Levis, Olga Frankfurt, et al.
Cancer Genetics|April 29, 2021
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AMLRobyn T Sussman, Bryan Manning, Daniel Ackerman, et al.
Drugs in R&D|September 24, 2024
Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid LeukemiaMathieu Quesnel-Vallières, David C Schultz, Alena Orlenko, et al.
Blood|November 7, 2007
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disordersElizabeth O Hexner, Cynthia Serdikoff, Mahfuza Jan, et al.
Experimental Hematology|June 28, 2011
Diagnostic microRNAs in myelodysplastic syndromeBegum Erdogan, Crystal Facey, Julianne Qualtieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2016
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell TransplantationMarlise R Luskin, Martin Carroll, David Lieberman, et al.
Pageof 19